Innovative payers are starting to look differently at how they build their pharmacy network, using a bottom-up approach to network design.
Access-based network design is an approach that can result in a significant reduction in prescription drug costs while ensuring that members maintain access to a network pharmacy. While the exact process for building an access-based network can vary based on a state's any-willing-provider laws and whether or not the plan is subject to such laws under ERISA, the basic approach follows a few principles:
Set an access standard. Quantify what access standard you want to provide for your members. For example, you may decide that you want to set a standard of 90% of your members living within six miles of a network pharmacy. Once you have quantified this access standard, your objective is to minimize costs while ensuring that the standard is achieved.
Define the prize. Let pharmacies know the number of pharmacies expected in the network. Ensure that pharmacies know their downside risk by basing reimbursement on effective rate guarantees or a cost-plus pricing methodology. By understanding downside risk, pharmacies can be more aggressive in their pricing.
Compete. Have pharmacies compete against each other to get into the network. Allow pharmacies to submit a second, more aggressive bid in order to be a preferred pharmacy that is granted a small copay advantage versus other pharmacies in the network.
Communicate. Announce the network and let members know that they have the option of lower copays at the preferred pharmacies in the network.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen